Sign in or Register   Sign in or Register
  |  

Mouse Anti-NRSN2 Recombinant Antibody (H-9) (CBMAB-N3627-WJ)

This product is a Mouse antibody that recognizes NRSN2. The antibody H-9 can be used for immunoassay techniques such as: WB, IP, IF, ELISA.
See all NRSN2 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
H-9
Application
WB, IP, IF, ELISA

Basic Information

Specificity
Human
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
Neurensin 2
Introduction
May play a role in maintenance and/or transport of vesicles.
Entrez Gene ID
UniProt ID
Alternative Names
Neurensin 2; C20orf98; Chromosome 20 Open Reading Frame 98; Neurensin-2; DJ1103G7.6;
Function
May play a role in maintenance and/or transport of vesicles.
Biological Process
Nervous system developmentManual Assertion Based On ExperimentIBA:GO_Central

Ren, S., Chen, M., Chen, Y., & Ding, K. (2023). NRSN2 is a Prognostic Biomarker in Gastric Cancer and Facilitates the Growth and Migration of Gastric Cancer Cells. Protein and Peptide Letters, 30(5), 427-438.

Wu, Y. B., Li, S. Y., Liu, J. Y., Xue, J. J., Xu, J. F., Chen, T., ... & Shen, C. (2023). Long non-coding RNA NRSN2-AS1 promotes ovarian cancer progression through targeting PTK2/β-catenin pathway. Cell Death & Disease, 14(10), 696.

Keremu, A., Aila, P., Tusun, A., Abulikemu, M., & Zou, X. (2022). Extracellular vesicles from bone mesenchymal stem cells transport microRNA-206 into osteosarcoma cells and target NRSN2 to block the ERK1/2-Bcl-xL signaling pathway. European Journal of Histochemistry: EJH, 66(3).

Chen, Q., Xie, J., & Yang, Y. (2022). Long non-coding RNA NRSN2-AS1 facilitates tumorigenesis and progression of ovarian cancer via miR-744-5p/PRKX axis. Biology of Reproduction, 106(3), 526-539.

Xu, T., Yan, Z., Lu, J., Chen, L., Li, X., Li, Y., ... & Guo, W. (2022). Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK1. Clinical & Experimental Metastasis, 39(5), 757-769.

Yan, Z., Xu, T., Lu, J., Wu, Z., Li, X., Xu, J., ... & Dong, Z. (2022). E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway. Pathology-Research and Practice, 236, 153963.

Li, F., Chen, X., Shang, C., Ying, Q., Zhou, X., Zhu, R., ... & Jiang, Z. (2021). Bone marrow mesenchymal stem cells-derived extracellular vesicles promote proliferation, invasion and migration of osteosarcoma cells via the lncRNA MALAT1/miR-143/NRSN2/Wnt/β-catenin axis. OncoTargets and therapy, 737-749.

Zhou, J., Xu, L., Yang, P., Lu, Y., Lin, S., & Yuan, G. (2021). The exosomal transfer of human bone marrow mesenchymal stem cell-derived miR-1913 inhibits osteosarcoma progression by targeting NRSN2. American Journal of Translational Research, 13(9), 10178.

Ren, F., Zhang, W., Lu, S., Ren, H., & Guo, Y. (2020). NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF‑κB signaling pathways. Oncology Letters, 19(1), 813-823.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-NRSN2 Recombinant Antibody (H-9)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare